|
|
Macular Degeneration
|
|
Macular Degeneration
[an error occurred while processing this directive]
Thanksgiving Menu Stuffed With Healthy Choices 23 Nov 2005
Collards are a rich source of lutein, an antioxidant that studies show may reduce the risk of age-related macular degeneration, a common cause of blindness. ...
- WBAL Channel.com,
IN SEASON: Sweet oranges 23 Nov 2005
These nutrients and phytochemicals have been shown to fight several kinds of cancer, heart disease, macular degeneration and other degenerative diseases. ...
- Birmingham News,
MIT Museum puts geneticist on ’Soap Box’ 23 Nov 2005
...of the Program in Medical and Population Genetics at the Broad Institute of MIT and Harvard, gave the example of age-related macular degeneration, a leading ...
- WebWire (press release),
The top ten super foods 23 Nov 2005
...disease. Broccoli also contains an antioxidant called lutein that can delay the progression of age-related macular degeneration (AMD). ...
- Daily Mail - UK,
BCAB marks 60 years 23 Nov 2005
Wilcox and rehab provider Janet Meyers team up to give folks, including aging baby boomers and elderly clients with macular degeneration, comprehensive exams ...
- Doylestown Central Bucks Life,
Lipitor linked to memory-loss episodes 23 Nov 2005
...to continue aspirin. Q: I've heard that taking vitamins may help prevent macular degeneration. What is the formula? A: The combination ...
- Daily Press,
Major Breakthrough In Treatment Of Macular Degeneration Nov 17, 2005
...blindness in adults. For the first time ever, there is a drug that offers real hope for people with macular degeneration. Results of ...
- NBC 10.com,
Helping Macular Degeneration Nov 16, 2005
November 16 - The leading cause of severe vision loss in people over age 50 is macular degeneration. Nearly 15 million Americans have it. ...
- ABC30.com,
Bacterium present in eyes with ’wet’ age-related macular ... Nov 9, 2005
...chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD). ...
- Innovations-Report,
Bacteria and Macular Degeneration Nov 10, 2005
...chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or “wet,� age-related macular degeneration (AMD). ...
- Technocrat.net,
Watchful eyes on macular degeneration Nov 14, 2005
By Nancy Vendrely. Age-related macular degeneration – AMD – is the leading cause of blindness for people age 55 and older in the United States. ...
- Fort Wayne Journal Gazette,
macular degeneration Injections appear to stem vision loss when ... Oct 23, 2005
THE QUESTION The most severe type of age-related macular degeneration, known as wet AMD because of leaking fluid from abnormal blood vessels in the eye, often ...
- Evansville Courier & Press (subscription),
Area doctors fight vision degeneration Nov 13, 2005
...deteriorate. Macular degeneration, a leading cause of severe vision loss for people over 65, affects more than 1.75 million Americans. ...
- Charlottesville Daily Progress,
What to Buy Grandma: Seniorstore.com Announces Five Tips for ... Nov 22, 2005
...low vision or arthritis? As seniors age, they may struggle with low vision due to macular degeneration or glaucoma. Find a low vision ...
- Emediawire (press release),
Scientists Link a Bacterium to Age-Related Blindness Nov 14, 2005
A bacterium linked to heart disease may also be a factor in age-related macular degeneration, the leading cause of blindness in people over 55 in the United ...
- New York Times,
Source: Crystal Research Associates, LLC Nov 22, 2005
Company also expects to conduct basic research to determine the potential use of its stem cells in other indications, such as macular degeneration, stroke, and ...
- PrimeZone (press release),
Animal-free lutein beadlet Nov 22, 2005
Several studies have shown a positive relationship between consumption of lutein and a lower incidence of age-related macular degeneration (AMD) and cataracts ...
- Ferret,
Wellness calendar Nov 8, 2005
Macular Degeneration support group: The Macular Degeneration Support Group will meet at 10 am in Cooling Auditorium of St. Vincent Hospital, 201 W. 86th St. ...
- Indianapolis Star,
Vitamins Combat Age-Related Blindness Nov 9, 2005
ISLAMABAD: Hundreds of thousands of people could benefit from vitamin supplements shown to help prevent macular degeneration, a condition that is the leading ...
- PakTribune.com,
Grateful for Turkey Nov 21, 2005
High intake of them is associated with a significant reduction in the risk of macular degeneration, the leading cause of blindness in older adults. ...
- Fort Wayne News Sentinel,
Ryckman: Fittest of feasts Nov 21, 2005
Good-for-you factor: Bread crust contains lots of antioxidants, which help fight heart disease, memory loss, cataracts and macular degeneration, among other ...
- Rocky Mountain News,
All 12-Month Follow-up Visits Completed in OccuLogix's Pivotal ... Nov 17, 2005
...of Rheopheresis for AMD, its pivotal stage clinical trial using its RHEO TM System to treat the dry form of age-related macular degeneration ("Dry AMD"). ...
- CCNMatthews (Communiqués de presse),
Sirna Therapeutics to Join the NASDAQ Biotechnology Index Nov 21, 2005
...stage biotechnology company developing RNAi-based therapies for serious diseases and conditions, including age- related macular degeneration (AMD), hepatitis B ...
- PR Newswire (press release),
Clearly better Nov 21, 2005
Most any cataract patient could opt for the ReSTOR lens except for those with macular degeneration or diabetic retinopathy in which years of diabetes has ...
- MLive.com,
Doing her best while doing without Nov 21, 2005
...them. Her stitches and her creativity are in her head. "Both eyes are bad," she said. The problem is macular degeneration. Comstock ...
- Albany Times Union,
Riva Centrale amenity complex complete Nov 19, 2005
Alexander M. Eaton, MD, founder and medical director of Retina Health Center and the Macular Degeneration Research Center, said a new office has opened at ...
- The News-Press,
'Superfoods' Everyone Needs Nov 17, 2005
...of these basic foods when he saw the positive results of a few simple diet changes in his patients suffering from age-related macular degeneration -- a leading ...
- CBS News
Clinical Trials Update: Nov. 21, 2005 Nov 21, 2005
...patients must be 50 years of age or older and have a doctor's diagnosis of choroidal neovascularization (CNV) due to age-related macular degeneration (AMD). ...
- Austin American-Statesman (subscription),
Love Your Losers Nov 21, 2005
One of biotech analyst Charly Travers' key investment theses for QLT was that its Visudyne product for age-related macular degeneration (AMD) would keep ...
- Motley Fool
Out of sight no reason to stop Nov 17, 2005
He was eventually diagnosed with age-related macular degeneration, a disease in which the light-sensing cells of the macula, a portion of the retina that makes ...
- Homer News,
Somewhere, Charles Darwin is smiling Nov 17, 2005
One drug, Macugen, is already on the market and is an effective treatment of age-related wet macular degeneration, a debilitating disease of the eyes. ...
- Yale Daily News
Sangamo BioSciences Announces Presentation at American Heart ... Nov 16, 2005
Other therapeutic development programs are focused on macular degeneration, ischemic heart disease, congestive heart failure, neuropathic pain, and infectious ...
- PR Newswire (press release),
OSI Pharmaceuticals Completes Its Acquisition of Eyetech ... Nov 14, 2005
The Company now has two major marketed products (for the treatment of cancer and age-related macular degeneration) and a robust product pipeline offering both ...
- Genetic Engineering News,
Drugs in Developement Nov 15, 2005
Planned new product submissions in addition to LAF237 and SPP100 include Lucentis, for the treatment of age-related macular degeneration in the European Union ...
- R&D Directions (subscription),
OSI Pharmaceuticals Completes Its Acquisition of Eyetech ... Nov 14, 2005
The Company now has two major marketed products (forthe treatment of cancer and age-related macular degeneration) and arobust product pipeline offering both ...
- Finanzen.net,
Preliminary Data from Second Pivotal Phase III Study Showed ... Nov 8, 2005
...drug Lucentis® (ranibizumab) met its one-year primary efficacy endpoint of maintaining vision in patients with wet age-related macular degeneration (AMD). ...
- PharmaLive.com (press release),
The eyes have it Nov 9, 2005
Its most promising product is Visagen, a steroid-based drug to treat macular degeneration, a gradual deterioration of sight frequently afflicting older adults. ...
- Salem News,
Acuity Medical Advancing Toward Commercialization with TheraMac(TM ... Oct 24, 2005
Clinical Trials in Process for Age-Related Macular Degeneration Treatment BRIGHTON, Mich., Oct. 24 /PRNewswire/ -- Acuity Medical ...
- PR Newswire (press release),
New Monthly Large Print News Journal "In-Sight" Began with a ... Nov 12, 2005
...news publications available for her 86-year-old father, Clifford – who suffered from low vision due to age-related macular degeneration – she promised him ...
- New Age Media Concepts (press release)
Eye drug maker QLT shares drop more than 9% after positive ... Nov 8, 2005
Genentech Inc. announced that its trial drug Lucentis was able to help patients with macular degeneration maintain their vision. QLT ...
- Canada.com,
Alcan, Fairmont, Magna International: Canadian Equity Preview Nov 8, 2005
The shares rose C$1.32, or 1.6 percent, to C$84.58. QLT Inc. (QLT CN): Genentech Inc. (DNA US) said in a statement that its macular-degeneration drug Lucentis ...
- Bloomberg
Canadian Stocks Fall; Magna, Alcan Shares Decline on Earnings Nov 8, 2005
...said in a statement that its macular-degeneration drug Lucentis was more effective than QLT's therapy Visudyne at preserving sight in patients with an ...
- Bloomberg
More to merger than meets the eye? Nov 15, 2005
One big question mark in the acquisition was Macugen, Eyetech's drug to treat macular degeneration, a major cause of vision loss in people over 60. ...
- Newsday,
OSI says it will delay purchase of Eyetech Nov 11, 2005
...by the Food and Drug Administration, Genentech's research data shows Lucentis could become a major rival to Eyetech's macular degeneration medication, Macugen. ...
- Newsday,
Readers tell stories of quitting cigarettes Nov 16, 2005
29, 2004. I had some symptoms of early macular degeneration. The doctor told me if I continued to smoke I was in danger of losing my sight. ...
- Charlotte Sun-Herald,
QLT shares fall on rival eye-drug results Nov 8, 2005
...head-to-head trial showed Lucentis met the primary goal of maintaining vision in patients with the "wet" form of age-related macular degeneration, the leading ...
- Metro Toronto,
Obstacle course simulates what it's like to be blind Nov 17, 2005
Martinez, who has been legally blind since birth due to macular degeneration, estimates that about 100 people have tried his obstacle course during the four or ...
- AZ Central.com,
OXiGENE's Vascular Disrupting Agents Paired with Anti-Angiogenic ... Nov 16, 2005
...combination therapies. It is also currently being studied in a Phase II clinical trial in myopic macular degeneration. OXiGENE believes ...
- Genetic Engineering News,
OSI Pharmaceuticals to Present at the Lazard Capital Markets ... Nov 18, 2005
Macugen(R)(pegaptanib sodium injection) is approved in the United States for thetreatment of neovascular age-related macular degeneration. ...
- Finanzen.net,
DSM introduces animal-free lutein beadlet form Nov 16, 2005
...applications. Lutein has been shown in studies to benefit eye health, protecting against cataracts and age-related macular degeneration. ...
- NutraIngredients.com,
East Bay Briefings Nov 17, 2005
30 at 11 am Saving Sight of Rhode Island will conduct the event, which will include screening for glaucoma, macular degeneration, diabetic retinopathy and ...
- Providence Journal (subscription),
Story By Linda Strowbridge Nov 17, 2005
...demanding, require computer skills she doesn't have or conflict with her need to care for her 87-year-old mother, who's suffering from macular degeneration. ...
- Owings Mills Times,
MethylGene Updates on Multi-Targeted Kinase Inhibitor Program ... Nov 16, 2005
...kinases and particularly those kinases involved in angiogenesis as treatments for cancer and other diseases such as macular degeneration, diabetic retinopathy ...
- CCNMatthews (press release),
Novartis Ophthalmics Recalls Seven Lots of GenTeal(R) Products in ... Nov 16, 2005
...research, development and manufacturing of leading ophthalmic pharmaceuticals that assist in the treatment of age-related macular degeneration, eye inflammation ...
- PR Newswire (press release),
Blind Beneficiaries Sue Social Security Administration - SSA Fails ... Nov 16, 2005
The most common causes of vision impairment in older Americans include age-related macular degeneration, glaucoma, cataracts, and diabetic retinopathy. ...
- PR Newswire (press release),
Miravant Announces Third Quarter Results for 2005 Nov 14, 2005
...we are excited to have commenced our Phase III confirmatory clinical trial for PHOTREX(TM) for the treatment of wet age-related macular degeneration (AMD). ...
- PharmaLive.com (press release),
Novartis reaches agreement to develop and commercialize glaucoma ... Nov 9, 2005
...leverage our well-established leadership and expertise in the treatment of back-of-the-eye diseases, such as 'wet' age-related macular degeneration (AMD), to ...
- Biotech Intelligence (press release),
Novadaq Announces Data Published in the JACC Nov 16, 2005
Novadaq's ophthalmic product, the OPTTX System, is aimed at the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD) by using the ...
- PR Newswire (press release),
Carl Zeiss Meditec Launches Comprehensive Non-Mydriatic Fundus ... Nov 17, 2005
...at 30- and 45- degree field angles allowing for early documentation of such conditions as diabetic retinopathy, age-related macular degeneration (AMD) and ...
- PR Newswire (press release),
Genaera Announces Third Quarter 2005 Financial Results Nov 9, 2005
...increases in clinical trial and manufacturing costs related to EVIZON(TM) (squalamine lactate) for the treatment of age-related macular degeneration (AMD) and ...
- PR Newswire (press release),
THE IRIS NETWORK ANNOUNCES NEW DIRECTION Nov 18, 2005
Recently a Low Vision Clinic has been opened to meet the needs of the ever-growing population of elderly Mainers with macular degeneration. ...
- MaineToday.com,
Carl Zeiss Meditec Launches Comprehensive Non-Mydriatic Fundus ... Nov 18, 2005
...images at 30- and45- degree field angles allowing for early documentation of such conditions asdiabetic retinopathy, age-related macular degeneration (AMD) and ...
- Advanced Imaging Pro (press release),
Nantucket Doll is prize in raffle at library Nov 18, 2005
When he learned that he was losing his vision to macular degeneration, he decided that he wanted to preserve the images that were so important to him. ...
- Holbrook Sun,
Men spared side effect from pain reliever Nov 10, 2005
I've heard that there are three new drugs for macular degeneration. What are they? ... I've heard that there are three new drugs for macular degeneration. ...
- Bradenton Herald,
Ex-NFL champ was a super friend, too Nov 16, 2005
But his friends were his real passion. Even when his eyesight was failing because of macular degeneration, Mr. Cole continued to play golf. ...
- Indianapolis Star,
LABEL HEAD GOES HERE Nov 17, 2005
...to continue aspirin. I've heard that taking vitamins may help prevent macular degeneration. What is the formula? The combination ...
- Bradenton Herald,
Lucentis maintains or improves vision in 95 percent of patients ... Nov 15, 2005
...drug Lucentis ( Ranibizumab ) met its one-year primary efficacy endpoint of maintaining vision in patients with wet age-related macular degeneration ( AMD ). ...
- Xagena.it,
OXiGENE Reports Third-Quarter 2005 Operational and Financial ... Oct 26, 2005
...resistant ovarian cancer, with radiotherapy for the treatment of non small cell lung cancer, and as a single agent therapeutic for myopic macular degeneration ...
- Genetic Engineering News,
Gene Therapy Trials Show Promise in Treating Age-Related Macular ... Nov 1, 2005
RNA duplex called small interfering RNA (siRNA), investigators are moving one step closer toward using gene therapy to combat age-related macular degeneration. ...
- DG News
Bacterium, Gene Play Roles in Elderly Vision Loss Nov 10, 2005
10 (HealthDay News) -- The diseased eye tissue of some patients with "wet" age-related macular degeneration (AMD) contains a bacterium called Chlamydia ...
- WWAY NewsChannel 3,
US: Tactile Alphabets for the Visually Impaired Nov 16, 2005
Towards this effort, the company has developed the ELIA Tactile Alphabet for people with macular degeneration, diabetic retinopathy, glaucoma, retinitis ...
- TheMatureMarket.com,
Lutein Supplements For Your Eyes Nov 4, 2005
...and tissues. It’s also been shown to decrease the risk of, and even reverse, age related macular degeneration (ARMD). ARMD is ...
- Bella Online
Squalamine (Evizon) Plus Photodynamic Therapy Safe and Effective ... Oct 24, 2005
...by IV squalamine lactate (Evizon) in the treatment of sub-foveal choroidal neo-vascularization associated with age-related macular degeneration seems produce ...
- DG News
Founder Dr. Ken M. Kengatharan Joins Athenagen to Lead Pre ... Nov 1, 2005
...could represent a novel class of drugs to treat diseases characterized by abnormal angiogenesis, including cancer, age-related macular degeneration and non ...
- PharmaLive.com (press release),
Successful Tests Of New Treatments In Mice For Eye Disease Causing ... Nov 1, 2005
New Drug Available For Treatment Of "Wet" Macular Degeneration Disease (February 18, 2005) -- A new drug for treatment of the wet form of age-related macular ...
- Science Daily (press release)
Sangamo BioSciences Reports 2005 Third Quarter Financial Results ... Oct 27, 2005
...programs, specifically the Company's ZFP TF programs for the potential treatment of diabetic neuropathy (DN), age-related macular degeneration (AMD) and its ZFN ...
- PR Newswire (press release),
Sight Loss Scandal Nov 14, 2005
I went to see someone last January who advised I had 'a little macular degeneration and to come back in a year', but they did not tell me that there was any ...
- PR Newswire UK (press release),
Acuity Medical Advancing Toward Commercialization with TheraMac(TM ... Oct 24, 2005
States for their pivotal pre- market clinical (PMA) trial for TheraMac(TM), a medical device for the treatment of dry age-related macular degeneration (AMD). ...
- PR Newswire (press release),
World Consortium Completes Human Genetic Variation Map Oct 27, 2005
Science, for example, scientists used HapMap data to uncover a genetic variation that increases the risk of age-related macular degeneration, the leading cause ...
- Washington File,
Earnings news helps depress TSX while auto, housing sectors worry ... Nov 8, 2005
Inc. announced that its trial drug Lucentis was able to help patients with macular degeneration maintain their vision. Lucentis ...
- CBC News,
A Slowdown for Toll Bros. Nov 8, 2005
...study of investigational drug Lucentis met its primary efficacy endpoint of maintaining vision in patients with the wet form of age-related macular degeneration ...
- BusinessWeek
OSI Pharmaceuticals has a bright future, officials say, but the ... Nov 1, 2005
Eyetech has a macular degeneration drug that OSI considers important to its future, but analysts questioned whether OSI was making a mistake by stepping ...
- Newsday,
As his world turns Nov 4, 2005
Jamison moved to Broomfield in 2002, 11 years after a crippling diagnosis of Stargardt's disease, a juvenile onset form of macular degeneration. ...
- Broomfield Enterprise (subscription),
Antioxidants Reduce Visual Acuity Loss in Patients with Advanced ... Oct 26, 2005
...and minerals reduced the 5-year risk of further loss of 3-line visual acuity in patients with advanced age-related macular degeneration (AMD), reported ...
- DG News
Genentech's Lucentis Could Be A Billion Dollar Drug Nov 8, 2005
The company said preliminary Phase III clinical data indicated 94% of patients with age-related macular degeneration (AMD) maintained or improved vision ...
- Forbes
TECH TICKER Nov 8, 2005
Lucentis was more effective than QLT's therapy Visudyne at preserving sight in patients with an aggressive form of age-related macular degeneration, the main ...
- San Jose Mercury News,
QLT shares slump Nov 8, 2005
Patients suffering from wet age-related macular degeneration also showed vision improvement after being treated with Genentech's Lucentis drug for 12 months. ...
- Globe and Mail,
QLT shares drop more than 10% after positive Genentech study ... Nov 8, 2005
...and Visudyne, the patients receiving Lucentis showed better results in maintaining the vision in patients with the wet form of age-related macular degeneration ...
- Canada.com,
OSI, Eyetech merger delayed Nov 10, 2005
Both Macugen and Lucentis are used to treat age-related macular degeneration, known as AMD, which is a leading cause of blindness in the elderly. ...
- MarketWatch
UPDATE 2-OSI wants time before completing Eyetech buy Nov 10, 2005
Both drugs are used to treat the "wet" form of age-related macular degeneration, but the data from the Lucentis trials suggests that Lucentis is significantly ...
- Reuters
QLT shares sag as rival reports positive drug trial results Nov 8, 2005
...shares followed the release of Genentech's Phase 3 trial of Lucentis, a drug used in the treatment of the wet form of age-related macular degeneration (AMD), a ...
- CBC Nova Scotia,
Rival's test result has QLT reeling Nov 9, 2005
Ever since QLT launched Visudyne in 2000 with partner Novartis AG, the drug has dominated the market for treating age-related macular degeneration, or AMD, the ...
- Globe and Mail,
OSI a Bit Unnerved by Lucentis Nov 10, 2005
Lucentis has been undergoing studies for a condition called wet age-related macular degeneration, for which Macugen was approved last December. ...
- TheStreet.com
Health for Life MD Nov 8, 2005
Earlier this year, researchers announced that they had found a gene responsible for 40 percent of the cases of macular degeneration, a common cause of blindness ...
- Newsweek
He gives life to a dying ritual Nov 10, 2005
So five years ago, though his eyes are under siege by macular degeneration and his knees battle with arthritis, he marched up the long sweep of the entrance to ...
- Seattle Post Intelligencer
Macular degeneration set to explode, warn doctors 03 Oct 2005
It took awhile for doctors to determine the cause, but when she heard the diagnosis, Gill couldn't believe her ears: age-related macular degeneration, or AMD. ...
- CTV.ca,
Prospecting in the Silver Age 03 Oct 2005
..."I can't drive or read," said Gallivan, a widow who has macular degeneration, a disease that has robbed her of all but peripheral vision. ...
- Wilkes Barre Times-Leader,
Corn is a sweet meal any time of year 03 Oct 2005
...a source of the yellow-orange pigment lutein, a powerful antioxidant most often hailed as a possible way to protect eyes from macular degeneration, fight cancer ...
- Rutland Herald,
Kentucky Senior Games Features 93 Year Old Swimmer 03 Oct 2005
Games. Riordan has macular degeneration and relies on her daughter Paula to help her get around, but in the pool, she's on her own. ...
- WTVQ,
Profits with a bedside manner 03 Oct 2005
One of Eyetech's biggest products in the pipeline, for treating macular degeneration, will compete against one of industry giant Genentech's products. ...
- Milwaukee Journal Sentinel,
Eye Saver Easy Reading Light Bulb useful in macular degeneration Sep 26, 2005
Such technology is particularly useful for those afflicted with macular degeneration, a common eye disease causing deterioration of the macula, the central ...
- RxPG NEWS,
Macular Degeneration Awareness Event Concludes: Archives Available ... Sep 28, 2005
Age-related macular degeneration is a deterioration of the retina which affects millions of seniors worldwide, causing varying levels of vision loss. ...
- PR Web (press release),
Alnylam pulls plug on macular degeneration drug Sep 20, 2005
...increased competition, Alnylam Pharmaceuticals said Tuesday that it was suspending development of a treatment for age-related macular degeneration, or AMD, a ...
- Investor's Business Daily (subscription)
Macular Degeneration Takes Eyesight, But It Doesn't Have to Steal ... Sep 18, 2005
...tape. But her life isn't as limited as she feared it would become when wet macular degeneration stole her central vision in 2000. ...
- The Ledger,
Smoking and Age Related Macular Degeneration (AMD) Sep 7, 2005
By Royal College of Ophthalmologists, Smoking greatly increases your chance of developing age-related macular degeneration (AMD), which leads to severe and ...
- RxPG NEWS,
Fruit intake may stave off macular degeneration Sep 1, 2005
...in the June 2004 issue of Archives of Ophthalmology suggests that fruit consumption may be one of the preventive keys to age-related macular degeneration (AMD ...
- Palladium-Item,
ARVO's Cogan Award to macular degeneration scientist Sep 1, 2005
...the award for his innovative investigations of iron metabolism and oxidative damage in the pathogenesis of age-related macular degeneration ( AMD ), including ...
- I-Newswire.com (press release)
Media Advisory - Age-Related Macular Degeneration Awareness Week ... Sep 14, 2005
The Awareness of Age-related Macular Degeneration and Associated Risk Factors report reveals surprising insights into Canadians' awareness of risk factors and ...
- Canada NewsWire (press release),
Smokers Risk Age-Related Macular Degeneration Sep 9, 2005
By Jeff Minerd, MedPage Today Staff Writer. BOLTON, England, Sept. 8-Age-related macular degeneration is linked to smoking, according to researchers here. ...
- MedPage Today,
Lenses little help for macular degeneration Sep 4, 2005
The question: To compensate for their loss of central vision, people with macular degeneration frequently look sideways at objects, forcing the eye to see ...
- Nashua Telegraph,
Medical Breakthrough -- Helping Macular Degeneration Sep 9, 2005
...numbers. Straight lines weren't straight anymore," she says. It was macular degeneration. She says it affected every hour of her day. ...
- WQAD,
Genentech in Competition With Itself on Eye Drug Sep 26, 2005
In the last few weeks many specialists have started using Avastin off-label as a treatment for age-related macular degeneration, the eye condition for which ...
- New York Times,
Radiation for macular degeneration Sep 28, 2005
Macular degeneration really means damage to the macula. ... For several years, doctors have been studying the use of radiation for treating macular degeneration. ...
- News 8 Austin,
Alnylam pulls plug on macular-degeneration drug Sep 20, 2005
...said Tuesday that it was suspending development of a treatment for age-related macular degeneration, or AMD, a leading cause of blindness in the elderly. ...
- Investor's Business Daily (subscription)
Sirna teams up with Allergan Sep 30, 2005
The 70-person firm formerly headquartered in Boulder, Colo., is testing an experimental drug for macular degeneration, making it a potential competitor to ...
- San Francisco Chronicle,
Sirna Therapeutics, Allergan in ophthalmology pact Sep 29, 2005
...(AGN) to develop Sirna-027, an age-related macular degeneration treatment, along with other compounds used to treat sight-threatening ocular diseases. ...
- MarketWatch
Congressman receives 'Brighter Vision Award' Sep 30, 2005
27 with representatives of The Seniors Coalition (TSC) and the AMD (Age-related Macular Degeneration) Alliance International to receive the 2005 Brighter ...
- Merrimack River Current,
Biotech, Drug Stocks Spun By Suits Oct 1, 2005
SG Cowen said Genentech's cancer drug Avastin may limit the potential of Lucentis, a developmental-stage treatment for age-related macular degeneration (AMD). ...
- Forbes
Sirna Therapeutics and Allergan Enter Into Strategic Ophthalmology ... Sep 29, 2005
...to develop Sirna-027, a novel RNAi-based therapeutic currently in Phase I for age-related macular degeneration (AMD), and to discover and develop other novel ...
- PharmaLive.com (press release),
QLT Inc. CEO Paul Hastings steps down, Robert Butchofsky named ... Sep 26, 2005
Though Visudyne is already approved in the US for predominantly classic age related macular degeneration, the company was testing the drug's efficacy in the ...
- National Post,
100th birthday bash for Manteca resident Sep 29, 2005
...all of their senses, sensibilities, memories and mental capacities intact, save for a little forgetfulness and a case of macular degeneration which has dimmed ...
- Manteca Bulletin,
On RNA and RNAi (RNA Interference or Silencing) Oct 1, 2005
...with radical new ways of tricking patients' RNA interference systems into fighting HIV-AIDS, Cancer, Hepatitis C, Macular Degeneration, Parkinsons, Alzheimer's ...
- CSI Files,
UTMB alumnus helps fund eye research Sep 19, 2005
...than $360,000 to the University of Texas Medical Branch at Galveston to support eye research involving the incurable eye disease macular degeneration, as well ...
- Daily News - Galveston County,
Sirna Therapeutics and Allergan Enter Into Strategic Ophthalmology ... Sep 29, 2005
...(NYSE: AGN - News) to develop Sirna-027, a novel RNAi-based therapeutic currently in Phase I for age-related macular degeneration (AMD), and to discover and ...
- Yahoo! News (press release)
Movers & Shakers Sep 29, 2005
...the Irvine, Calif., pharmaceutical developer, agreed on a multiyear deal to develop Sirna-027, a Phase I drug to treat age-related macular degeneration. ...
- MarketWatch
Sirna Partners With Allergan on AMD Sep 29, 2005
...eligible for up to $245 million in milestone payments as the companies develop Sirna's genetically based treatment for age-related macular degeneration, or AMD ...
- MSN Money
Genentech's Avastin May Limit Lucentis' Potential Sep 26, 2005
While Lucentis has been widely pegged as the biggest competitive threat to Macugen, the only age-related macular degeneration (AMD) treatment co-marketed by ...
- Forbes
Highlights of rising and falling US stocks Sep 29, 2005
Francisco biotech company and partner Allergan (AGN) agreed on a multiyear deal to develop Sirna-027, a Phase I drug to treat age-related macular degeneration. ...
- Investor's Business Daily (subscription)
Allergan, Sirna sign drug development deal Sep 29, 2005
...drug delivery technologies, said it will assume development and commercialization responsibilities for Sirna's age-related macular degeneration (AMD) drug ...
- Bizjournals.com,
Sirna Therapeutics to Summarize Program Progress and Strategic ... Sep 29, 2005
...stage biotechnology company developing RNAi-based therapies for serious diseases and conditions, including age-related macular degeneration (AMD), hepatitis B ...
- PharmaLive.com (press release),
Novartis, new products portfolio Oct 1, 2005
Lucentis ( ranibizumab ), the potential new "gold standard" treatment for wet age-related macular degeneration ( AMD ), the leading cause of blindness in ...
- Xagena.it,
QLT CEO resigns amid differences with board Sep 26, 2005
...this time last year on a number of issues, including concern that competition will hurt the company's market share in treating age-related macular degeneration ...
- Metro Toronto,
Sirna and Allergan to collaborate on eye disease drugs Sep 30, 2005
...entered into a multi-year alliance with Allergan to develop Sirna-027, a novel RNAi-based therapeutic currently in phase I for age-related macular degeneration ...
- Pharmaceutical Business Review
Sirna Therapeutics Granted Broad Patent Covering RNAi-Mediated ... Sep 27, 2005
...conserved sequences which are shared between two or more genes offers a unique therapeutic approach to diseases such as age-related macular degeneration (AMD). ...
- PR Newswire (press release),
FDA Confuses Consumers by Allowing Dubious Health Claims on Foods ... Sep 29, 2005
...reduce the risk of food allergies in infants, lycopene may reduce the risk of cancer, and that lutein may reduce the risk of cataracts and macular degeneration ...
- Consumer Affairs
THE PILOT LIGHT: Retired Admiral To Address Group Sep 26, 2005
Award was presented to Republican Congressman Howard Coble Tuesday by The Seniors Coalition and the Age-related Macular Degeneration Alliance International. ...
- Southern Pines Pilot,
Cystic Fibrosis Foundation Funds Production of Cell Lines by ... Sep 29, 2005
Other therapeutic development programs are focused on macular degeneration, ischemic heart disease, congestive heart failure, neuropathic pain, and infectious ...
- PR Newswire (press release),
QLT Inc. stock down sharply after disappointing test results for ... Sep 21, 2005
...called the results negative for the prospects of Visudyne to be used in the treatment of occult and minimally classic age related macular degeneration. ...
- National Post,
GenVec invests $15M from stock sale into drug Sep 30, 2005
Church. GenVec is also developing Biobypassae for severe coronary artery disease and Adpedf for age-related macular degeneration. ...
- Business Gazette,
10 things to make with walnuts Sep 29, 2005
..."When incorporated into a healthy diet and lifestyle, walnuts can play a role in preventing age-related macular degeneration, a leading cause of blindness," he ...
- OCRegister (subscription),
Potential role of amyloid-beta in the pathogenesis of age-related ... Sep 26, 2005
By Journal of Clinical Investigation, Age-related macular degeneration (AMD) is the main cause of blindness in patients over the age of 60. ...
- RxPG NEWS,
Oxford Biomedica Plc announces Interim Results Sep 19, 2005
I/II trial in Parkinson's disease anticipated to start in 2006 - Preclinical efficacy data with RetinoStat(R) for age-related macular degeneration presented at ...
- Market Wire (press release)
QLT Falls on Eye Treatment Study Sep 21, 2005
...research - Cramer's Take) failed to reduce the risk of vision loss after two years in a subgroup of patients with age-related macular degeneration, sending the ...
- TheStreet.com
Drug companies, Blue Cross debate restricting coverage for eye ... Sep 14, 2005
The disease is advanced "age-related macular degeneration," said by the Macular Degeneration Foundation to be "the leading cause of blindness" responsible for ...
- Asbury Park Press,
Drugs designed for Heart protection also protect your eyes Sep 3, 2005
ISLAMABAD, September 04 (Online): Macular degeneration is the leading cause of vision loss. There's no cure, but researchers have ...
- PakTribune.com,
Genentech to file for FDA ok for Lucentis in December Sep 7, 2005
In a press release Wednesday, Genentech said its Phase IIIb clinical study of Lucentis in the treatment of wet age-related macular degeneration will evaluate ...
- MarketWatch
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data ... Sep 12, 2005
...today announced that preclinical animal efficacy data from its program to develop a ZFP Therapeutic(TM) for age-related "wet" macular degeneration (AMD) were ...
- Yahoo! News (press release)
QLT CEO resigns Sep 25, 2005
...to improve vision loss after two years in a late-stage clinical study of 364 patients with the occult form of wet age-related macular degeneration (AMD), the ...
- Globe and Mail,
UPDATE 1-Genentech shares down, analyst cuts Lucentis outlook Sep 26, 2005
...earlier this month that it planned to file in December for US approval of Lucentis as a treatment for "wet form" age-related macular degeneration, a leading ...
- Reuters
Analysts move Genentech, Eyetech Sep 26, 2005
...that Avastin, which is approved to treat colorectal cancer, has become increasingly popular in the treatment of wet age-related macular degeneration, or AMD. ...
- MarketWatch
Off-Label Avastin May Sink Lucentis Sep 26, 2005
...earnings estimates for Genentech because more and more eye doctors are prescribing the cancer drug as a treatment for age-related macular degeneration, or AMD ...
- Forbes
After failing to breathe new life into QLT, Hastings steps down Sep 27, 2005
And there's more trouble in paradise as Visudyne's leadership in treating wet age-related macular degeneration (AMD) is being eroded by the recent launch of ...
- Globe and Mail,
QLT shares fall Sep 21, 2005
The Vancouver-based company said late Tuesday the Visudyne trial was part of a broader series for the treatment of wet macular degeneration, a major cause of ...
- Globe and Mail,
Novartis Presents Positive Phase III Data on Key Compounds and ... Sep 19, 2005
Planned new product submissions in addition to LAF and SPP include Lucentis (age-related macular degeneration) in the EU, LDT600 (hepatitis B) in both the US ...
- PrimeZone (press release),
Regeneron to cut 165 workers Sep 27, 2005
Regeneron, which employs 721 companywide, is pursuing the VEGF Trap as both a cancer treatment and a treatment for age-related macular degeneration. ...
- Albany Times Union,
Regeneron Narrows Focus As VEGF Trap Speeds On Sep 26, 2005
Also on Regeneron's plate is the VEGF Trap to treat wet age-related macular degeneration (AMD) through an intravitreal injection into the eye. ...
- BioWorld Online (subscription),
VEGF Trap Oncology Program with Sanofi-Aventis Planned to Expand ... Sep 26, 2005
Regeneron is developing the VEGF Trap for the treatment of the neovascular form of age-related macular degeneration (wet AMD) utilizing intravitreal (or direct ...
- Business Wire (press release),
CCSO: Community Policing officer goes beyond the call of duty Sep 26, 2005
One example is her involvement in the plight of an 83-year-old woman suffering from macular degeneration who lost her mobile home to Hurricane Charley. ...
- Charlotte Sun-Herald,
Drug stocks zig-zag in trade Sep 26, 2005
...report issued by SG Cowen on Monday which noted that Avastin was being increasingly used to treat the eye disease wet age-related macular degeneration, or AMD. ...
- Investor's Business Daily (subscription)
New Treatment, New Hope for People Suffering from Dry AMD Sep 28, 2005
28 /PR Direct/ - With an aging population and with 2.1 million Canadians already suffering from some form of the age-related macular degeneration (AMD), Veris ...
- PR Direct (press release),
09-27-05 The Firing Line Sep 26, 2005
...molecule that was derived from random information using Darwinian molecular evolution is now clinically available for the treatment of wet macular degeneration ...
- Daily Texan,
Health Notes Sep 21, 2005
Call 800-955-4572. REGION. Macular degeneration clinical trial. Newly diagnosed patients with wet macular degeneration may be eligible ...
- Times Herald-Record,
MultiCell Technologies Makes Investor Presentation Available on ... Sep 26, 2005
...and Immunosuppression and Stem Cell Immunostimulation, also has applications for the treatment of Multiple Sclerosis, Type 1 Diabetes and Macular Degeneration. ...
- Business Wire (press release),
'VEGF Trap' oncologisch programma zal door samenwerking met Sanofi ... Sep 26, 2005
VEGF Trap Program in Eye Disease Regeneron is developing the VEGF Trap for the treatment of the neovascular form of age-related macular degeneration (wet AMD ...
- Netherlands Corporate News,
Placenta Stem Cells Are the Most Promising Healer of Our Time ... Sep 26, 2005
Gehrig's disease), lupus erythematosus (LE), Alzheimer's, Parkinson's, cancers, and especially diseases of the eye such as macular degeneration and retinitis ...
- Business Wire (press release),
Attention News Editors: Sep 26, 2005
...and commercialize products which meet significant medical needs in spinal cord injury and retinal eye diseases, such as macular degeneration and glaucoma. ...
- Canada NewsWire (press release),
LIFELONG HEALTH : Antioxidants give boost to disease-fighting ... Sep 25, 2005
They also are powerful antioxidants, and diets rich in carotenoids are associated with a lower risk of colon cancer, cataracts and perhaps macular degeneration ...
- Arkansas Democrat-Gazette (subscription),
Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion ... Sep 16, 2005
...recommending approval of Macugen(R) (pegaptanib sodium injection) for the treatment of neovascular (wet) age- related macular degeneration (neovascular AMD). ...
- PR Newswire (press release),
The eyes are the first to go Sep 25, 2005
...business. She pushed away the machine, and we studied the photographs of my eyes. There were no signs of macular degeneration. "You ...
- Rocky Mount Telegram,
What gas crisis? Central Jerseyans find other ways of getting ... Sep 29, 2005
While he has had other cameras, Rother, who said he has macular degeneration, joked that "now I have the Canon idiot camera with a little telescope lens." He ...
- Bridgewater Courier News,
Memories Of Dr. George Young Sep 27, 2005
...avid reader with an inquisitive mind even getting a video eye television system so he could continue reading as he began to lose vision to macular degeneration ...
- The Chattanoogan,
picks new executive Sep 28, 2005
Magnification of Chicago. The company sells products that help people with visual impairments, such as macular degeneration. Sullivan said ...
- Northwest Herald,
Yellow lights up mesa on Color Sunday Sep 26, 2005
Thatcher, who lives in Grand Junction and suffers from macular degeneration, has lost her ability to focus on objects and recognize many colors. ...
- Grand Junction Sentinel,
Health cancel hears about cataracts, other vision concerns Sep 20, 2005
Seventy-five percent of the time, that is the only thing wrong. Macular degeneration is a major concern now, which causes poor vision. ...
- Cherokee County Herald,
If it's Friday, it must be challah Sep 27, 2005
Program, she recently shared her bread-machine challah technique with a group of seniors who are losing their vision, mostly because of macular degeneration. ...
- Daytona Beach News-Journal,
Ludlow Lions sponsor Eye Ball benefit Sep 27, 2005
It will provide detection of eye disease such as glaucoma, diabetic retinopathy, macular degeneration and vision loss as well as hearing loss and high blood ...
- The Republican,
'Keeping Current' project needs more to read to visually impaired Sep 21, 2005
Marjorie Toven, who has had macular degeneration for the last 10 years is an avid listener to the broadcast. She said, “To me it is certainly heaven sent. ...
- Grand Rapids Herald Review,
Feast on Foods. Sep 26, 2005
Lycopene, the pigment that makes tomatoes red, also appears to reduce risk for cardiovascular disease, some cancers, and macular degeneration, the leading ...
- Afternoon Dispatch & Courier,
New Affymetrix Microarray Set Genotypes More Than 500,000 SNPs in ... Sep 28, 2005
100K Array Set have demonstrated the power of this approach through significant early discoveries in diseases like macular degeneration, cardiovascular disease ...
- PharmaLive.com (press release),
Local family donates saddle Sep 28, 2005
...mother. McIrvin's wife, Judy, had just been diagnosed with macular degeneration before they discovered McIrvin was ill with cancer. ...
- Green River Star,
Drugs designed for Heart protection also protect your eyes Sep 3, 2005
ISLAMABAD: Macular degeneration is the leading cause of vision loss. ... Collier has wet macular degeneration, a deterioration of the retina that blurs focus. ...
- Online - International News Network,
Smokers twice as likely to go blind Sep 5, 2005
The link between smoking and AMD (age-related macular degeneration) is now as robust as the link between smoking and lung cancer, yet few people are aware of ...
- News Wales,
17,000 blinded by fags Sep 6, 2005
...and lung cancer. The cigarettes cause a form of blindness called Age-Related Macular Degeneration, known as AMD. Smoke destroys ...
- The Sun,
A hazy picture? Sep 13, 2005
...the eye doctor forever. * AGE-RELATED MACULAR DEGENERATION (ARMD): This is a relatively new bane of old age. There is formation ...
- Expressindia.com,
Highlights of rising and falling US stocks Sep 26, 2005
...bell, saying its checks indicate Avastin is increasingly being used on an off-label basis for the treatment of wet age-related macular degeneration, a trend ...
- Investor's Business Daily (subscription)
UPDATE 1-Genentech says FDA denies fast-track for Lucentis Sep 7, 2005
The drug is designed to treat "wet form" age-related macular degeneration, a leading cause of blindness for people over the age of 60 in North America. ...
- Reuters
Genentech Announces Plans to File for FDA Approval of Lucentis for ... Sep 7, 2005
...and Drug Administration (FDA) regarding plans to initiate a Phase IIIb clinical study of Lucentis for patients with wet age-related macular degeneration (AMD). ...
- PR Newswire (press release),
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Macular Degeneration
you may want to try searching the Internet using the Google search box below.
|
|
|
